Related Experiment Video
Updated: Apr 7, 2026

Author Spotlight: Effect of Left Atrial Ligation on Avian Embryonic Hearts and HLHS Implications
Published on: June 16, 2023
The myocardial and coronary histopathology and pathogenesis of hypoplastic left heart syndrome
Charles R Cole1, Pirooz Eghtesady2
11University of Cincinnati,Cincinnati,Ohio,United States of America.
Insights
Hypoplastic left heart syndrome (HLHS) is a severe congenital heart defect with a high mortality rate. Further research into its pathology and associated conditions is needed to understand its causes and find a cure.
Area of Science:
- Cardiology
- Developmental Biology
- Genetics
Background:
- Hypoplastic left heart syndrome (HLHS) is a critical congenital heart defect (CHD) with a near-uniform fatal outcome without intervention.
- The etiology of HLHS remains largely unknown, hindering the development of effective treatments or cures.
- The condition presents significant genetic and anatomical heterogeneity, necessitating a re-evaluation of existing hypotheses.
Purpose of the Study:
- To explore the pathogenesis of HLHS by examining its distinct myocardial and coronary pathology.
- To investigate the association between HLHS and endocardial fibroelastosis (EFE).
- To provide a comprehensive review to guide future research directions.
Main Methods:
- Literature review focusing on HLHS.
- Analysis of histological and vascular variations in HLHS.
- Evaluation of the relationship between HLHS and EFE.
Main Results:
- HLHS exhibits unique myocardial and coronary pathologies.
- A significant association exists between HLHS and the endocardial fibroelastosis reaction.
- Genetic and anatomical heterogeneity are key features of HLHS.
Conclusions:
- Understanding the specific pathologies of HLHS is crucial for elucidating its pathogenesis.
- The association with EFE warrants further investigation.
- Further research into the histological and vascular variations of HLHS is essential for advancing treatment strategies.
Abstract:
Hypoplastic left heart syndrome has the greatest mortality rate among all CHDs and without palliation is uniformly fatal. Despite noble efforts, the aetiology of this syndrome is unknown and a cure remains elusive. The genetic and anatomic heterogeneity of hypoplastic left heart syndrome supports a rethinking of old hypotheses and warrants further investigation into the histological and vascular variations recognised with this syndrome. In an effort to elucidate the pathogenesis of hypoplastic left heart syndrome, this review will focus on its unique myocardial and coronary pathology as well as evaluate the association of hypoplastic left heart syndrome with the endocardial fibroelastosis reaction.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Myocarditis I: Introduction
Pathophysiology of Heart Failure
Cardiomyopathy V: Interprofessional Care
Heart Failure II: Pathophysiology

